Predictive Technology Group, Inc. (OTCMKTS: PRED) is a research and development company specializing in technology-driven healthcare and wellness solutions. Founded in the mid-2010s, the company has evolved from its early focus on energy technology into a diversified biomedical enterprise. Its core mission is to harness predictive analytics, digital therapeutics, and advanced delivery systems to address chronic and age-related health conditions.
The company’s primary business activities encompass the development, formulation and commercialization of integrative biomedical products. Key offerings include neuromodulation devices designed to support cognitive function, nutraceutical formulations targeting metabolic and inflammatory pathways, and digital health platforms that leverage remote monitoring and mobile applications. By combining hardware, software and proprietary compound libraries, Predictive Technology Group aims to deliver personalized interventions that improve patient outcomes.
Headquartered in Las Vegas, Nevada, Predictive Technology Group maintains research collaborations and manufacturing partnerships across North America and Europe. The company works closely with academic institutions and contract development organizations to accelerate product validation and regulatory approvals. Its global distribution channels extend into select markets in Asia and Latin America, with ongoing efforts to establish strategic alliances for broader commercialization.
Under the guidance of an experienced management team, Predictive Technology Group is led by executives with backgrounds in biotechnology, clinical research and regulatory affairs. The board includes professionals who have driven product launches at major pharmaceutical and medical device companies. Looking ahead, the company continues to expand its pipeline through in-licensing agreements, joint ventures and targeted acquisitions aimed at bolstering its predictive health platform.
AI Generated. May Contain Errors.
